Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

BACKGROUND: The efficacy of ceftazidime-avibactam—a cephalosporin–β-lactamase inhibitor combination with in vitro activity against Klebsiella pneumoniae carbapenemase–producing carbapenem-resistant Enterobacteriaceae (CRE)—compared with colistin remains unknown. METHODS: Patients initially treated w...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Infect Dis
Auteurs principaux: van Duin, David, Lok, Judith J, Earley, Michelle, Cober, Eric, Richter, Sandra S, Perez, Federico, Salata, Robert A, Kalayjian, Robert C, Watkins, Richard R, Doi, Yohei, Kaye, Keith S, Fowler, Vance G, Paterson, David L, Bonomo, Robert A, Evans, Scott
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Articles and Commentaries
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850032/
https://ncbi.nlm.nih.gov/pubmed/29020404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix783
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires